Alphabet is set to report Q2 results, but investors are prioritizing the company's massive capital expenditure figures over traditional metrics like revenue and earnings as a key indicator for the AI boom.
Intel is set to report quarterly results on Thursday, with investors closely watching to see if strong AI-driven demand and progress in its manufacturing business can justify a stock rally that has seen its shares soar this year.
Yum Brands' Taco Bell is experiencing a significant drop in customer traffic and a stock price decline following a foodborne illness outbreak, though market analysts believe the brand's damage will be temporary.
Shares of Cal-Maine Foods, the largest U.S. egg producer, fell sharply after the company reported a fiscal fourth-quarter loss and revenue that significantly missed analyst expectations, citing deteriorating market conditions.
The work management software provider is cutting approximately 20% of its staff to focus on its AI strategy, leading to an upgraded forecast for its full-year operating margin.
A new Medicare pilot program for obesity medications is revealing a strong patient preference for injectable drugs like Wegovy and Zepbound over oral alternatives, a trend driven by higher demonstrated weight-loss results.
Following the loss of over 3,000 employees and significant leadership turnover, biotech industry experts are calling for the U.S. Food and Drug Administration to ensure its drug approval process is guided by scientific integrity, not political pressure.
India's benchmark stock indices, the Nifty 50 and BSE Sensex, ended Wednesday's session lower amid widespread losses in the IT, banking, and real estate sectors. A spike in the India VIX volatility index signaled rising investor caution.
A lawsuit alleging Meta Platforms used discriminatory AI to select employees for layoffs is highlighting the significant legal and evidentiary hurdles workers face, particularly due to binding arbitration agreements and lack of access to internal company data.
